Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA.
Am Heart J. 2009 Dec;158(6):933-40. doi: 10.1016/j.ahj.2009.10.013.
There are little data regarding outcomes in patients with angina and severe coronary artery disease (CAD) treated with medical management. Using the Duke Databank of Cardiovascular Disease, we describe the prevalence and long-term outcomes of patients with angina and multivessel CAD treated medically after catheterization.
Patients undergoing catheterization for angina (chest pain without recent revascularization or myocardial infarction) with severe CAD (>or=75% stenosis in >or=2 epicardial vessels) were identified (n = 8,555). One and five year outcomes in the 32% (n = 2,776) of patients who did not receive revascularization in the 30 days after catheterization were described. Predictors of 1-year death, cardiac rehospitalization, and late revascularization in this population were identified.
The population had a median age of 66, were mostly male, had significant comorbidities, and most had prior revascularization. Outcomes were poor at 1 and 5 years: death (11% and 37%), cardiac rehospitalization (29% and 61%), and late revascularization (10% and 27%). The cumulative rate of death, myocardial infarction, late revascularization, or cardiac rehospitalization occurred in 38% at 1 year and 76% at 5 years. Prior coronary artery bypass grafting was the only variable independently associated with protection from death, cardiac rehospitalization, and late revascularization.
Medical management after catheterization is a common in patients with severe CAD and angina. Of patients treated with medical management, one third will have a recurrent cardiac event within the first year highlighting the poor outcomes and high utilization of resources by this patient population.
关于接受药物治疗的心绞痛和严重冠状动脉疾病(CAD)患者的结果数据较少。我们利用杜克心血管疾病数据库,描述了经导管检查后接受药物治疗的心绞痛和多支 CAD 患者的患病率和长期结果。
确定了因心绞痛(无近期血运重建或心肌梗死的胸痛)而行导管检查且 CAD 严重(>或=2 个心外膜血管中有>或=75%狭窄)的患者(n=8555)。描述了在导管检查后 30 天内未接受血运重建的 32%(n=2776)患者的 1 年和 5 年结果。确定了该人群中 1 年死亡、心脏再住院和晚期血运重建的预测因素。
该人群的中位年龄为 66 岁,主要为男性,合并有严重的合并症,大多数患者有既往血运重建史。1 年和 5 年的结果较差:死亡(11%和 37%)、心脏再住院(29%和 61%)和晚期血运重建(10%和 27%)。1 年时累积的死亡、心肌梗死、晚期血运重建或心脏再住院的发生率为 38%,5 年时为 76%。既往冠状动脉旁路移植术是与死亡、心脏再住院和晚期血运重建保护相关的唯一变量。
在严重 CAD 和心绞痛患者中,经导管检查后进行药物治疗是一种常见的治疗方法。在接受药物治疗的患者中,三分之一的患者在 1 年内会再次发生心脏事件,这突出了该患者群体的不良结局和高资源利用率。